Cargando…
Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer
Pancreatic cancer is the 5(th) leading cause of cancer deaths, and there are no effective treatments. We developed a poxvirus platform vaccine with improved immunogenicity and inserted the mesothelin gene to create an anti-mesothelin cancer vaccine. Mesothelin expression is mostly restricted to tumo...
Autores principales: | White, Michael, Freistaedter, Andrew, Jones, Gwendolyn J. B., Zervos, Emmanuel, Roper, Rachel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825036/ https://www.ncbi.nlm.nih.gov/pubmed/29474384 http://dx.doi.org/10.1371/journal.pone.0193131 |
Ejemplares similares
-
Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer
por: Zervos, Emmanuel, et al.
Publicado: (2016) -
Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020) -
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
por: Zhang, Xianyu, et al.
Publicado: (2022) -
From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma
por: Montemagno, Christopher, et al.
Publicado: (2020) -
Modulating Mesothelin Shedding to Improve Therapy
por: Zhang, Yujian, et al.
Publicado: (2012)